The ability of hepatitis B virus (HBV) to stimulate the expression of a cellular gene was investigated by using a transient-expression system. A plasmid in which the expression of the bacterial chloramphenicol acetyltransferase (cat) gene had been placed under the control of the DNA sequences that regulate the expression of the human beta-interferon gene was constructed. In Vero cells, cotransfection of the 2.7-kilobase BglII DNA fragment of HBV together with the test plasmid containing the cat gene resulted in stimulation of the expression of the cat gene. This HBV DNA fragment was specific in its trans-activation; no significant stimulation of CAT activity was observed in constructs when the promoter and enhancer elements were derived from the murine sarcoma viral long terminal repeat, Rous sarcoma virus, BK virus, or simian virus 40. Results of subcloning of the HBV DNA fragment indicate that the trans-activating function resides in a 944-base-pair EcoRV-BglII DNA fragment of the HBV genome that contains the X structural gene and its promoter element. Removal of the promoter from the X structural gene resulted in loss of the trans-activating function. A frameshift mutation within the X gene region also eliminated the trans-activating activity. These results suggest that the X antigen could play a role in HBV infections by activating the expression of cellular genes.
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Hepatitis B virus (HBV) is a small, enveloped virus that contains a partially double-stranded DNA genome (40) . The DNA sequences of the HBV genomes isolated from various patients are heterogeneous (41) , but the genomes have always been found to consist of four open reading frames (ORF). One of these regions codes for the HBV surface antigen (5, 43) , and another encodes the HBV core antigen (32) . The ORF that codes for the HBV core antigen also contains the information for the HBV e antigen (24) . The largest ORF encompasses most of the genome and presumably encodes the DNA polymerase (41) . The fourth and the smallest ORF, designated X, could specify a protein of approximately 154 amino acids (39) , but to date, no HBV protein of this size has been identified in HBV-infected cells.
Inspection of the nucleotide sequence upstream from the 5' end of the ORF X revealed the absence of the typical consensus TATA box, which is usually found about 30 base pairs (bp) from the RNA cap site (4). However, an RNA species of approximately 900 nucleotides in length that hybridizes to the ORF X has been detected in rodent cells transfected with HBV DNA (15) . Furthermore, a region that is 17 to 408 bp upstream from the ORF X region has been shown to contain a promoter element capable of regulating the expression of the bacterial chloramphenicol acetyltransferase (cat) gene (42) .
A fusion protein containing 145 amino acids encoded by ORF X of HBV has been expressed in Escherichia coli, and this fusion protein reacts to human sera of individuals infected with HBV but not to normal human sera (28 The HBV DNA inserts in the various plasmids are diagrammed in Fig. 1 .
The construction of the beta-interferon cat hybrid gene is shown in Fig. 2 . The 1.6-kbp HindIII DNA fragment that contains the human beta-interferon-coding sequence and the regulatory DNA sequence was constructed from pIFR (46 (45) . After incubation with the added DNA for 4 to 8 h, the cell monolayer was rinsed with serum-free medium and treated with 15% glycerol for 1.5 min at room temperature; 10 ml of fresh medium was then added. In all transfections, 10 ,ug of various plasmids containing HBV DNA and 10 ,ug of the plasmid containing the cat gene were used.
Treatment of transfected cells with poly(I) -poly(C). Transfected Vero cells were treated with poly(I) poly(C) as described by Havell and Vilcek (17) . After 48 h of transfection, cell monolayers were washed with phosphate-buffered saline and treated with 5 ml of serum-free Eagle minimum essential medium containing 50 gig of poly(I) * poly(C) per ml and 600 ,ug of DEAE-dextran per ml. After 2 h, cycloheximide (50 ,ug/ml) was added, and incubation was continued for 3.5 h. Actinomycin D was then added at a concentration of 1 ,ig/ml for 30 min. The treated cells were then washed twice with phosphate-buffered saline and incubated for 12 to 16 h in Eagle minimum essential medium containing 2% fetal calf serum. Control cells were treated in the same manner, except that poly(I) poly(C) was omitted.
CAT assays. Cells were harvested and CAT assays were performed essentially as described by Gorman et al. (14) . Untreated (Fig. 3) . The basal CAT activity from the P-ifnR-cat construct was very low (lane 1). Upon 3 and 4) . Lanes 5 and 6 represent CAT activity in cells transfected with pSV2CAT. Cells were either treated with poly(I) poly(C) (even-numbered lanes) or mock treated (oddnumbered lanes). Cells were harvested, and equal amounts of extracts were assayed for CAT activity. %Ac, Percent acetylation; CM, chloramphenicol. activity in these transfectants increased by fivefold (lane 2). In other experiments, the increase in CAT activity after the treatment of cells with poly(I) * poly(C) ranged from 4-to 10-fold. Although increased CAT activity occurred upon treatment with poly(I) -poly(C), the strength of the inducible beta-interferon-regulatory elements was clearly less than that of the SV40 early promoter and enhancer elements (lanes 5 and 6). Extracts of poly(I) poly(C)-treated Vero cells that received the 13-ifnR-cat construct together with the 2,755-bp BglII HBV DNA that contains the genes for the surface antigen and for the X antigen showed approximately a 400% increase in the expression of the cat gene (lanes 3 and 4). In other experiments, the extent of the activation of CAT activity in the cotransfected Vero cells was proportional to increasing amounts of HBV DNA in the transfection mixture; optimal activation was obtained when 10 ,ug of plasmid containing HBV DNA was used (data not shown).
Subcloning of the HBV DNA fragment containing the transactivating function. Since the 2,755-bp BgIII fragment of HBV DNA contains the genes for the surface antigen and for the X antigen, various subclones of this fragment were constructed in order to identify the biologically active DNA region. The plasmids containing the various HBV DNA fragments that are diagrammatically represented in Fig. 1 were used to cotransfect Vero cells with pTWU54 to assess their ability to trans-activate the cat gene. As controls, pUC9 and pTWU14 were used as cotransfecting DNA. Cotransfection with the BglII-EcoRV HBV DNA fragment (mp, 2429 to 1040) that contains the gene for the surface antigen had no effect on the expression of the cat gene (Fig. 4) . However, the presence of pTWU17 (EcoRVBglII HBV DNA fragment that contains the X gene with its 5'-and 3'-flanking sequences) resulted in the activation of CAT activity. The level of trans-activation caused by pTWU17 was comparable with that caused by pTWU14. Of interest is the observation that trans-activation of the expression of the ,B-ifnR-cat construct by pTWU17 occurred in the absence of treatment of transfected cells with poly(I) poly(C); in this case, a 15-fold increase in CAT (Fig. 3, lane 8) . A si activation by the 2,755-bp BglII fragment (pT seen in the absence of poly(I) * poly(C) treatn consistently (see Fig. 5, lane 3) . These results the trans-activating activity is due to a product X region.
Confirmation of these results was obtained HBV DNA sequence that contains the structura lacks the native promoter. Since the putative p within the EcoRV-NcoI fragment of HBV DNA 1372; unpublished data), the NcoI-BglII HBV ment (mp, 1372-1984) was used as the source tural X gene (pTWU18). Cotransfection of Ve: pTWU54 and pTWU18 did not result in a signif in the expression of the cat gene in cells that treated or induced with poly(I) poly(C) (Fig. 4,  11) . When the structUiral X gene was placed bel heterologous promoter, such as the SV40 early p enhancer (pTWU19), the trans-activating acti stored (Fig. 4, lanes 12 and 13) . Frameshift (29) . A possible mechanism for the development of hepatocellular carcinoma could be that the trans-activating properties of the HBV X antigen can result in cell transformation by activation of a cellular gene(s), resulting in tumor formation after a long latent period. Since the HBV genome has been found to be integrated into the cellular genome within the HBV X gene region (7, 20, 35) , it is possible that a fusion protein consisting of part of the X antigen and part of a cellular protein could possess trans-activating activity.
The HBV X gene has many features in common with the pX genes of human T cell lymphotropic virus type I (HTLV-I), HTLV-I1, and HTLV-III/human immunodeficiency virus. Both genes are located at the 3' ends of the linearized genomes, share the codon preference of eucaryotic genes, and encode proteins that display trans-activating activity (6, 27, 29) . Furthermore, like the HBV X gene, the pX gene is not an oncogene, yet HTLV-I is clearly oncogenic. Moreover, HBV has been implicated as a potential cofactor in the establishment of the acquired immunodeficiency syndrome (31) . Epidemiological studies have indicated that a majority of patients with acquired immunodeficiency syndrome have prior or concurrent infections with HBV. Since HBV DNA has been detected in peripheral blood mononuclear cells (36) , an intriguing possibility is that the HBV X antigen is involved in the expression of human immunodeficiency virus by functioning as a transcriptional activator.
Other viral proteins that have been shown to trans- a Vero cells were cotransfected with equal amounts of the indicated test plasmid and of pUC9, pTWU14, or pElA as described in Table 1 , footnote a. The cells that received pTWU54 were either treated with poly(I) poly(C) or mock treated prior to CAT assays. CAT activity is expressed as the percentage of substrate that was acetylated.
activate homologous target promoters in transient-expression assays include the SV40 large T antigen (2, 3), the MS-EA protein of Epstein-Barr virus (22) , the IE proteins of herpes simplex virus (8, 12) , and the Tat protein of human inmmunodeficiency virus (6) . Adenovirus ElA (1, 30), pseudorabies IE regulatory proteins (16, 18) , and p40x of HTLV-I (27) are viral regulatory proteins that are also capable of trans-activating the expression of some cellular genes. All these viral trans-acting proteins function by increasing transcription from the target promoters. These observations are consistent with the supposition that the activation of transcription by viral proteins involves the better use of cellular transcriptional factors.
Since other viral proteins known to have trans-activating properties perform key regulatory roles in infection, it is possible that the HBV X protein has a regulatory role in HBV infections. Such a role would be consistent with the observation that the X ORF exhibits a high degree of conservation among the HBV DNAs isolated from different patients; less than a 4% divergence among the encoded amino acid sequences was detected (39) . Cloning and sequencing of other HBV subtypes also indicated the conservation of the X gene region (10, 19, 38) . Other members of the hepadnavirus group, such as ground squirrel hepatitis virus and woodchuck hepatitis virus but not duck hepatitis virus, contain regions of the genome that correspond to the ORF X of HBV (11, 25, 34) .
